Key result
Higher aortic stiffness linked to ~23% increased risk of incident albuminuria in type 2 diabetes.
Why the study?
Does higher aortic stiffness predict incident albuminuria and decline in eGFR in patients with type 2 diabetes?
Population
461 Japanese adults with type 2 diabetes and normo- or microalbuminuria, mean age 59, 43.2% female.
Comparison
Higher aortic stiffness vs Lower aortic stiffness
Design
Cohort
Follow-up
median 5.9 years
Authors
Loading...
May flag higher renal risk in type 2 diabetes; leaves open whether stiffness-targeted therapy alters progression.
Cohort (n=461)
No
Does higher aortic stiffness predict incident albuminuria and decline in eGFR in patients with type 2 diabetes?
Hazard Ratio: 1.23 (95% CI 1.13–1.33)
Absolute Event Rate: 19.4% vs 8.5%
p-value: p=<0.001
Aortic stiffness is an independent predictor of albuminuria progression and eGFR decline in patients with type 2 diabetes, suggesting a link between macrovascular hemodynamics and microvascular kidney damage.
Bouchi et al. (2011) conducted a cohort in Type 2 diabetes with normo- or microalbuminuria (n=461). Higher aortic stiffness (cf-PWV ≥9.1 m/s or continuous) vs. Lower aortic stiffness (cf-PWV <9.1 m/s) was evaluated on Transition from normo- to microalbuminuria or micro- to macroalbuminuria (HR 1.23, 95% CI 1.13-1.33, p=<0.001). Higher aortic stiffness was significantly associated with an increased risk of incident albuminuria (HR 1.23) and a faster decline in glomerular filtration rate in patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: